Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients

Journal of Viral Hepatitis

Volumn 18, Issue 10, 2011, Pages

  Roque Cuellar M C ^a   Sanchez B ^a   Garcia Lozano J R ^a   Praena Fernandez J M ^b   Nunez Roldan A ^a   Aguilar Reina, J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b Instituto de Biomedicina de Sevilla   (Spain)

Author keywords

flow cytometry; HCV peptides; occult infection; real time PCR; sexual partners; T cell response

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4; NONSTRUCTURAL PROTEIN 5; NONSTRUCTURAL PROTEIN 5B; VIRUS ANTIBODY; VIRUS PROTEIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HEPATITIS C VIRUS; HETEROSEXUALITY; HUMAN; INFECTION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; SERODIAGNOSIS; VIRUS DETECTION; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C, CHRONIC; HETEROSEXUALITY; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-4; LECTINS, C-TYPE; MALE; MIDDLE AGED;

EID: 80052858499     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01464.x     Document Type: Article

References (46)

1. Deuffic-Burban S, Poynard T, Sulkowski MS, Wong JB,. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J Viral Hepat 2007; 14: 107-115. (Pubitemid 46146705)
2. Nakayama H, Sugai Y, Ikeya S, Inoue J, Nishizawa T, Okamoto H,. Molecular investigation of interspousal transmission of hepatitis C virus in two Japanese patients who acquired acute hepatitis C after 40 or 42 years of marriage. J Med Virol 2005; 75: 258-266. (Pubitemid 40053737)
3. Halfon P, Riflet H, Renou C, Quentin Y, Cacoub P,. Molecular evidence of male-to-female sexual transmission of hepatitis C virus after vaginal and anal intercourse. J Clin Microbiol 2001; 39: 1204-1206. (Pubitemid 32209755)
4. Marincovich B, Castilla J, Del Romero J, et al. Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples. Sex Transm Infect 2003; 79: 160-162. (Pubitemid 36469626)
5. Vandelli C, Renzo F, Romano L, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol 2004; 99: 855-859. (Pubitemid 39090213)
6. Renou C, Halfon P,. High-risk behaviour and sexual transmission of hepatitis C. Am J Gastroenterol 2005; 100: 246-247.
7. Balogun MA, Ramsay ME, Parry JV, et al. A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection. Sex Transm Infect 2003; 79: 301-306. (Pubitemid 37026348)
8. Tahan V, Karaca C, Yildrim B, et al. Sexual transmission of HCV between spouses. Am J Gastroenterol 2005; 100: 281-284.
9. Boonyarad V, Chutaputti A, Choeichareon S, et al. Interspousal transmission of hepatitis C in Thailand. J Gastroenterol 2003; 38: 1053-1059. (Pubitemid 38016365)
10. Quer J, Murillo P, Esteban JI, Martell M, Esteban R, Guardia J,. Sexual transmission of hepatitis C virus from a patient with chronic disease to his sex partner after removal of an intrauterine device. Sex Trasm Dis 2003; 30: 470-471. (Pubitemid 36605498)
11. Magder LS, Fix AD, Mikhail NNH, et al. Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data. Int J Epidemiol 2005; 34: 160-165. (Pubitemid 40347388)
12. Pekler VA, Robbins WA, Nyamathi A, Yashina TL, Leak B, Robins TA,. Use of versant TMA and bDNA 3.0 assays to detect and quantify hepatitis C virus in semen. J Clin Lab Anal 2003; 17: 264-270. (Pubitemid 37523319)
13. Alary M, Joly JR, Vincelette J, Lavoie R, Turmel B, Remis RS,. Lack of evidence of sexual transmission of hepatitis C virus in a prospective cohort study of men who have sex with men. Am J Public Health 2005; 95: 502-505. (Pubitemid 40315130)
14. Buffington J, Murray PJ, Schlanger K, et al. Low prevalence of HCV-antibody in men who had sex with men who do not inject drugs. Public Health Rep 2007; 122: 63-67. (Pubitemid 47443834)
15. Kamal SM, Amin A, Madwar M, et al. Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J Virol 2004; 78: 12252-12258. (Pubitemid 39458745)
16. Castillo I, Bartolomé J, Quiroga JA, Barril G, Carreño V,. Hepatitis C virus infection in the family setting of patients with occult hepatitis C. J Med Virol 2009; 81: 1198-1203.
17. Pham TN, King D, Macparland SA, et al. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 2008; 134: 812-822. (Pubitemid 351312726)
18. Pham TN, Mercer SE, Michalak TI,. Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles. J Viral Hepat 2009; 16: 547-556.
19. Schulze zur Wiesch J, Lauer GM, Day CL, et al. Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 2005; 175: 3603-3613. (Pubitemid 41292019)
20. Aberle JH, Formann E, Steindl-Munda P, et al. Prospective study of viral clearance and CD4+ T-cell response in acute hepatitis C primary infection and reinfection. J Clin Virol 2006; 36: 24-31. (Pubitemid 44360574)
21. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K,. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991; 175: 220-228.
22. BD Biosciences. BD FastImmune™ cytokine flow cytometry. In:, Ernst D, ed. Techniques for Immune Function Analysis Application Handbook, 1st edn. San Diego, CA: BD Biosciences, 2003: 85-90.
23. Beeler A, Zaccaria L, Kawabata T, Gerber BO, Pichler WJ,. CD69 up regulation on T cells as an in vitro marker for delayed-type drug hypersensitivity. Allergy 2008; 63: 181-188.
24. Castillo I, Rodríguez-Iñigo E, Lõpez-Alcorocho JM, Pardo M, Bartolomé J, Carreño V,. Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment. Clin Infect Dis 2006; 43: 1277-1283. (Pubitemid 44706453)
25. Quiroga JA, Llorente S, Castillo I, et al. Cellular immune responses associated with occult hepatitis C virus infection of the liver. J Virol 2006; 80: 10972-10979. (Pubitemid 44706538)
26. Zeremski M, Shu MA, Brown Q, et al. Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users. J Viral Hepat 2009; 16: 10-20.
27. Thurairajah PH, Hegazy DM, Chokshi S, et al. Hepatitis C virus (HCV)-specific T cell responses in injection drug users with apparent resistance to HCV infection. J Infect Dis 2008; 198: 1749-1755.
28. Freeman AJ, Ffrench RA, Post JJ, et al. Prevalence of production of virus-specific interferon-gamma among seronegative hepatitis C-resistant subjects reporting injection drug use. J Infect Dis 2004; 190: 1093-1097. (Pubitemid 39186796)
29. Semmo N, Day CL, Ward SM, et al. Preferential loss of IL-2 secreting CD4+ T helper cells in chronic HCV infection. Hepatology 2005; 41: 1019-1028. (Pubitemid 40593910)
30. Kamal SM, Fehr J, Roesler B, Peters T, Rasenack JW,. Peginterferon alone or with ribavirin enhances HCV-specific CD4+ T-Helper 1 responses in patients with chronic hepatitis C. Gastroenterology 2002; 123: 1070-1083.
31. Gigi E, Raptopoulou-Gigi M, Kalogeridis A, et al. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease. J Viral Hepat 2008; 15: 145-154.
32. Miner KT, Croft M,. Generation, persistence, and modulation of Th0 effector cells: role of autocrine IL-4 and IFN-γ. J Immunol 1998; 160: 5280-5287. (Pubitemid 28267814)
33. Ho LJ, Shaio MF, Chang DM, Liao CL, Lai JH,. Infection of human dendritic cells by dengue virus activates and primes T cells towards Th0-like phenotype producing both Th1 and Th2 cytokines. Immunol Invest 2004; 33: 423-437.
34. Shata MT, Tricoche N, Perkus M, et al. Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees. Virology 2003; 314: 601-616. (Pubitemid 37209981)
35. Jin B, Wang RY, Qiu Q, et al. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA. Immunology 2007; 122: 15-27. (Pubitemid 47222591)
36. Diepolder HM, Zachoval R, Hoffmann RM, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346: 1006-1007.
37. Bronowicki JP, Vetter D, Uhl G, et al. Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients. J Infect Dis 1997; 176: 518-522. (Pubitemid 27328779)
38. Welker MW, Zeuzem S,. Occult hepatitis C: How convincing are the current data? Hepatology 2009; 49: 665-675.
39. Pham TN, Coffin CS, Michalak TI,. Occult hepatitis C virus infection: what does it mean? Liver Int 2010; 30: 502-511.
40. Pham TN, Michalak TI,. Occult persistence and lymphotropism of hepatitis C virus infection. World J Gastroenterol 2008; 14: 2789-2793.
41. Marukian S, Jones CT, Andrus L, et al. Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 2008; 48: 1843-1850.
42. Carreño V, Bartolomé J, Castillo I, Quiroga JA,. Hepatitis C virus replication in patients with occult hepatitis C virus infection. Hepatology 2009; 49: 2128-2129.
43. Moreno-Otero R,. Desperately seeking hepatitis C virus. World J Gastroenterol 2008; 14: 2946-2947.
44. Quiroga JA, Llorente S, Castillo I, et al. Virus-specific T-cell response associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection. J Med Virol 2006; 78: 1190-1197. (Pubitemid 44182235)
45. Scognamiglio P, Accapezzato D, Casciaro MA, et al. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. J Immunol 1999; 162: 6681-6689. (Pubitemid 29309393)
46. Al-Sherbiny M, Osman A, Mohamed N, et al. Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion. Am J Trop Med Hyg 2005; 73: 44-49. (Pubitemid 41278744)